Oral Posaconazole in High Risk Patients With Gastrointestinal Dysfunction (Study P05115)
NCT00686543
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
75
Enrollment
INDUSTRY
Sponsor class
Conditions
Fungal Infection
Acute Myelogenous Leukemia
Neutropenia
Interventions
DRUG:
Posaconazole
Sponsor
Merck Sharp & Dohme LLC